Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Q2 results

- PMLiVE

Merck granted FDA approval for Keytruda combination in cervical cancer

The decision marks the third FDA-approved indication for Keytruda in cervical cancer

- PMLiVE

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer

Approximately 7,400 new cases of the disease are diagnosed in the UK every year

- PMLiVE

Unmet Needs and Novel Advances at the 2023 Women’s Health Master Class

On November 8-9, Medscape Education held the 2nd Annual Women’s Health Master Class—Modernizing Women's Health: Elevating Quality Care for Everyday Practice, two days dedicated to bringing the latest advances in...

Medscape Education Global

- PMLiVE

Merck to acquire Caraway Therapeutics in a deal worth up to $610m

The deal gives Merck access to a pipeline of therapeutics for neurodegenerative and rare diseases

- PMLiVE

A Passionate Cause: Elevating Women to Reshape Medicine

“We need more outstanding leaders from underrepresented communities, including women and those from different ethnicities”, says Antonella Chadha Santuccione, co-founder and CEO of the nonprofit Women's Brain Project in Zurich,...

Medscape Education Global

- PMLiVE

Merck receives FDA approval for Keytruda combination in gastric cancer

An estimated 26,500 people in the US will be diagnosed with gastric cancer in 2023

Hear from her: Message from the Women in Medicine Summit “Be the Change you Want to See”

Medscape Education Global

Hear from her: Changing what’s possible for Women in Healthcare

Medscape Education Global

Hear from her: Meet your hosts

Every day, women leaders are changing the healthcare landscape for the better. Our Women in Healthcare Leadership Podcast Series features some of the women working to elevate equity, achieve gender...

Medscape Education Global

- PMLiVE

Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia

The deals aim to accelerate drug development in oncology, neurology and immunology

- PMLiVE

Merck receives EC approval for Keytruda combination in gastric cancer

Over one million new cases of gastric cancer were diagnosed globally in 2020

- PMLiVE

MSD and Astex announce expansion to oncology drug discovery collaboration

Astex will receive $35m upfront plus milestone payments totalling $500m per programme

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links